Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Intellia Therapeutics awarded inducement grants to six new employees on June 1, 2026. The grants consist of 47,150 time-based restricted stock units (RSUs) vesting annually over three years.
Key figures
- New employees
- 6
- Shares granted
- 47150
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.